Cover Page - shares	9 Months Ended
Cover Page - shares	Nov. 02, 2019	Dec. 05, 2019
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Nov. 02, 2019
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Registrant Name	AstroNova, Inc.
Entity Central Index Key	0000008146
Current Fiscal Year End Date	--01-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Trading Symbol	ALOT
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	false
Title of 12(b) Security	Common Stock
Security Exchange Name	NASDAQ
Entity Address, State or Province	RI
Entity Common Stock, Shares Outstanding		7,069,568

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Nov. 02, 2019	Jan. 31, 2019
CURRENT ASSETS
Cash and Cash Equivalents	$ 4,468	$ 7,534
Accounts Receivable, net	22,094	23,486
Inventories, net	35,594	30,161
Prepaid Expenses and Other Current Assets	3,059	1,427
Total Current Assets	65,215	62,608
Property, Plant and Equipment, net	11,323	10,380
Intangible Assets, net	26,454	29,674
Goodwill	12,110	12,329
Deferred Tax Assets, net	3,482	2,928
Right of Use Assets	1,767
Other Assets	1,014	1,064
TOTAL ASSETS	121,365	118,983
CURRENT LIABILITIES
Accounts Payable	6,674	5,956
Accrued Compensation	2,968	5,023
Other Liabilities and Accrued Expenses	3,789	2,911
Current Portion of Long-Term Debt	5,116	5,208
Revolving Credit Facility	6,500	1,500
Current Liability – Royalty Obligation	2,000	1,875
Current Liability – Excess Royalty Payment Due	419	1,265
Deferred Revenue	387	373
Income Taxes Payable		554
Total Current Liabilities	27,853	24,665
NON CURRENT LIABILITIES
Long-Term Debt, net of current portion	9,004	12,870
Royalty Obligation, net of current portion	8,488	9,916
Lease Liabilities, net of current portion	1,350
Deferred Tax Liabilities	539	40
Other Long-Term Liabilities	1,178	1,717
TOTAL LIABILITIES	48,412	49,208
SHAREHOLDERS' EQUITY
Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 10,333,915 shares and 10,218,559 shares at November 2, 2019 and January 31, 2019, respectively	518	511
Additional Paid-in Capital	55,870	53,568
Retained Earnings	51,142	49,511
Treasury Stock, at Cost, 3,279,831 and 3,261,672 shares at November 2, 2019 and January 31, 2019, respectively	(33,454)	(32,997)
Accumulated Other Comprehensive Loss, net of tax	(1,123)	(818)
TOTAL SHAREHOLDERS' EQUITY	72,953	69,775
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 121,365	$ 118,983

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Nov. 02, 2019	Jan. 31, 2019
Statement of Financial Position [Abstract]
Common Stock, Par Value	$ 0.05	$ 0.05
Common Stock, Shares Authorized	13,000,000	13,000,000
Common Stock, Shares Issued	10,333,915	10,218,559
Treasury Stock, Shares	3,279,831	3,261,672

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2019	Oct. 27, 2018	Nov. 02, 2019	Oct. 27, 2018
Income Statement [Abstract]
Revenue	$ 33,318	$ 34,196	$ 102,967	$ 99,490
Cost of Revenue	21,021	20,288	64,454	60,073
Gross Profit	12,297	13,908	38,513	39,417
Operating Expenses:
Selling and Marketing	6,944	6,587	20,122	19,484
Research and Development	2,076	2,123	5,868	5,844
General and Administrative	2,830	2,836	8,445	8,298
Operating Expenses	11,850	11,546	34,435	33,626
Operating Income	447	2,362	4,078	5,791
Other Expense, net	(238)	(538)	(788)	(1,320)
Income before Income Taxes	209	1,824	3,290	4,471
Income Tax (Benefit) Provision	(247)	407	182	1,046
Net Income	$ 456	$ 1,417	$ 3,108	$ 3,425
Net Income per Common Share—Basic:	$ 0.06	$ 0.21	$ 0.44	$ 0.50
Net Income per Common Share—Diluted:	$ 0.06	$ 0.20	$ 0.43	$ 0.49
Weighted Average Number of Common Shares Outstanding-Basic	7,047	6,925	7,013	6,858
Weighted Average Number of Common Shares Outstanding-Diluted	7,199	7,167	7,272	7,056

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2019	Oct. 27, 2018	Nov. 02, 2019	Oct. 27, 2018
Statement of Comprehensive Income [Abstract]
Net Income	$ 456	$ 1,417	$ 3,108	$ 3,425
Other Comprehensive Income (Loss), Net of Taxes and Reclassification Adjustments:
Foreign Currency Translation Adjustments	87	(157)	(166)	(775)
Change in Value of Derivatives Designated as Cash Flow Hedge	62	221	62	766
Losses (Gains) from Cash Flow Hedges Reclassified to Income Statement	3	(150)	(201)	(605)
Realized Loss on Securities Available for Sale Reclassified to Income Statement				3
Other Comprehensive Income (Loss)	152	(86)	(305)	(611)
Comprehensive Income	$ 608	$ 1,331	$ 2,803	$ 2,814

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Beginning Balance at Feb. 01, 2018	$ 63,647	$ 500	$ 50,016	$ 45,700	$ (32,397)	$ (172)
Beginning Balance, Shares at Feb. 01, 2018		9,996,120
Share-Based Compensation	363		363
Employee Option Exercises	489	$ 3	574		(88)
Employee Option Exercises, Shares		53,010
Restricted Stock Awards Vested, net	(40)	$ 1	(1)		(40)
Restricted Stock Awards Vested, net, Shares		16,981
Cash Dividend—$0.07 per share	(480)			(480)
Net Income	814			814
Other Comprehensive Income (Loss)	(163)					(163)
Ending Balance at Apr. 28, 2018	64,630	$ 504	50,952	46,034	(32,525)	(335)
Ending Balance, Shares at Apr. 28, 2018		10,066,111
Beginning Balance at Feb. 01, 2018	63,647	$ 500	$ 50,016	$ 45,700	$ (32,397)	$ (172)
Beginning Balance, Shares at Feb. 01, 2018		9,996,120
Net Income	3,425
Other Comprehensive Income (Loss)	$ (611)
Ending Balance at Oct. 27, 2018		$ 510
Ending Balance, Shares at Oct. 27, 2018	67,408	10,196,755	52,948	47,693	(32,960)	(783)
Beginning Balance at Apr. 28, 2018	$ 64,630	$ 504	$ 50,952	$ 46,034	$ (32,525)	$ (335)
Beginning Balance, Shares at Apr. 28, 2018		10,066,111
Share-Based Compensation	466		466
Employee Option Exercises	183		461		(278)
Employee Option Exercises, Shares		40,302
Restricted Stock Awards Vested, net	(156)	$ 3	(2)		(157)
Restricted Stock Awards Vested, net, Shares		30,084
Cash Dividend—$0.07 per share	(481)			(481)
Net Income	1,194			1,194
Reclassification of Certain Income Tax Effects from Accumulated Other Comprehensive Loss	14			14
Other Comprehensive Income (Loss)	(362)					(362)
Ending Balance at Jul. 28, 2018	65,488	$ 507	51,877	46,761	$ (32,960)	(697)
Ending Balance, Shares at Jul. 28, 2018		10,136,497
Share-Based Compensation	510		510
Employee Option Exercises	564	$ 3	$ 561
Employee Option Exercises, Shares		54,952
Restricted Stock Awards Vested, net, Shares		5,306
Cash Dividend—$0.07 per share	(485)			(485)
Net Income	1,417			$ 1,417
Other Comprehensive Income (Loss)	$ (86)					$ (86)
Ending Balance at Oct. 27, 2018		$ 510
Ending Balance, Shares at Oct. 27, 2018	67,408	10,196,755	52,948	47,693	(32,960)	(783)
Beginning Balance at Jan. 31, 2019	$ 69,775					$ (818)
Other Comprehensive Income (Loss)						(305)
Ending Balance at Nov. 02, 2019	72,953	$ 518	$ 55,870	$ 51,142	$ (33,454)	(1,123)
Ending Balance, Shares at Nov. 02, 2019		10,333,915
Beginning Balance at Feb. 01, 2019	69,775	$ 511	53,568	49,511	(32,997)	(818)
Beginning Balance, Shares at Feb. 01, 2019		10,218,559
Share-Based Compensation	601		601
Employee Option Exercises	296	$ 1	306		(11)
Employee Option Exercises, Shares		27,990
Restricted Stock Awards Vested, net	(69)	$ 1	(1)		(69)
Restricted Stock Awards Vested, net, Shares		9,522
Cash Dividend—$0.07 per share	(489)			(489)
Net Income	1,700			1,700
Other Comprehensive Income (Loss)	(200)					(200)
Ending Balance at May. 04, 2019	71,614	$ 513	54,474	50,722	(33,077)	(1,018)
Ending Balance, Shares at May. 04, 2019		10,256,071
Beginning Balance at Feb. 01, 2019	$ 69,775	$ 511	53,568	49,511	(32,997)	(818)
Beginning Balance, Shares at Feb. 01, 2019		10,218,559
Employee Option Exercises, Shares	55,175
Net Income	$ 3,108
Other Comprehensive Income (Loss)	(305)
Ending Balance at Nov. 02, 2019	72,953	$ 518	55,870	51,142	(33,454)	(1,123)
Ending Balance, Shares at Nov. 02, 2019		10,333,915
Beginning Balance at May. 04, 2019	71,614	$ 513	54,474	50,722	(33,077)	(1,018)
Beginning Balance, Shares at May. 04, 2019		10,256,071
Share-Based Compensation	451		451
Employee Option Exercises	199	$ 1	198
Employee Option Exercises, Shares		13,821
Restricted Stock Awards Vested, net	(377)	$ 2	(2)		(377)
Restricted Stock Awards Vested, net, Shares		45,658
Cash Dividend—$0.07 per share	(493)			(493)
Net Income	951			951
Other Comprehensive Income (Loss)	(257)					(257)
Ending Balance at Aug. 03, 2019	72,088	$ 516	55,121	51,180	(33,454)	(1,275)
Ending Balance, Shares at Aug. 03, 2019		10,315,550
Share-Based Compensation	525		525
Employee Option Exercises	226	$ 2	224
Employee Option Exercises, Shares		18,365
Cash Dividend—$0.07 per share	(494)			(494)
Net Income	456			456
Other Comprehensive Income (Loss)	152					152
Ending Balance at Nov. 02, 2019	$ 72,953	$ 518	$ 55,870	$ 51,142	$ (33,454)	$ (1,123)
Ending Balance, Shares at Nov. 02, 2019		10,333,915

Condensed Consolidated Statements of Changes in Shareholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Nov. 02, 2019	Aug. 03, 2019	May 04, 2019	Oct. 27, 2018	Jul. 28, 2018	Apr. 28, 2018
Statement of Stockholders' Equity [Abstract]
Cash dividend per share	$ 0.07	$ 0.07	$ 0.07	$ 0.07	$ 0.07	$ 0.07

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Nov. 02, 2019	Oct. 27, 2018
Cash Flows from Operating Activities:
Net Income	$ 3,108	$ 3,425
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:
Depreciation and Amortization	4,692	4,633
Amortization of Debt Issuance Costs	37	38
Share-Based Compensation	1,576	1,339
Deferred Income Tax Provision		(67)
Changes in Assets and Liabilities:
Accounts Receivable	1,296	248
Inventories	(5,412)	(1,140)
Income Taxes	(2,639)	(244)
Accounts Payable and Accrued Expenses	(1,586)	(4,793)
Other	(84)	(916)
Net Cash Provided by Operating Activities	988	2,523
Cash Flows from Investing Activities:
Proceeds from Sales/Maturities of Securities Available for Sale		1,511
Honeywell Asset Purchase and License Agreement—TSA Agreement Payment		(400)
Additions to Property, Plant and Equipment	(2,422)	(1,902)
Net Cash Used by Investing Activities	(2,422)	(791)
Cash Flows from Financing Activities:
Net Cash Proceeds from Common Shares Issued Under Employee Benefit Plans and Employee Stock Option Plans, Net of Payment of Minimum Tax Withholdings	276	1,041
Borrowings under Revolving Credit Facility	5,000	3,000
Repayment under Revolving Credit Facility		(1,500)
Payment of Minimum Guarantee Royalty Obligation	(1,375)	(1,250)
Principal Payments of Long-Term Debt	(3,998)	(4,012)
Dividends Paid	(1,477)	(1,446)
Net Cash Used by Financing Activities	(1,574)	(4,167)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(58)	74
Net Decrease in Cash and Cash Equivalents	(3,066)	(2,361)
Cash and Cash Equivalents, Beginning of Period	7,534	10,177
Cash and Cash Equivalents, End of Period	4,468	7,816
Supplemental Disclosures of Cash Flow Information:
Cash Paid During the Period for Interest	350	449
Cash Paid During the Period for Income Taxes, Net of Refunds	2,746	3,154
Schedule of Non-Cash Financing Activities:
Value of Shares Received in Satisfaction of Option Exercise Price	$ 11	$ 366

Business and Basis of Presentation

9 Months Ended

Nov. 02, 2019

Business and Basis Of Presentation [Abstract]

Business and Basis of Presentation

Note 1 – Business and Basis of Presentation

Overview

Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are employed around the world in a wide range of applications in the aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation industries. In the United States, the Company has factory-trained direct field salespeople located in major cities from coast to coast. We also have direct field sales or service centers in Canada, China, Denmark, France, Germany, India, Malaysia, Mexico, Singapore, Spain and the United Kingdom staffed by our own employees and dedicated third-party contractors. Additionally, we utilize over 150 independent dealers and representatives selling and marketing our products in over 50 countries.

The business consists of two segments, Product Identification

(“PI”) and Test & Measurement (“T&M”)

. The Product Identification segment offers a variety of hardware and software products and associated supplies that allow customers to mark, track and enhance the appearance of their products. PI includes specialty printing systems and supplies sold under the QuickLabel

®

, TrojanLabel

®

and GetLabels

™

brand names. PI products are used in industrial and commercial product packaging, branding and labeling applications to print custom labels, packaging materials and corresponding visual content

to enable our customers to

digitally

print on-demand in their own facilities

. The Test & Measurement segment includes systems sold under the AstroNova

®

brand name as well as the Company’s line of aerospace flight deck printers. Products sold under the AstroNova brand enable our customers to acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats. In the aerospace market, the Company has a long history of using its data visualization technologies to provide networking systems and high-resolution light-weight flight deck and cabin printers.

Unless otherwise indicated, references to “AstroNova,” the “Company,” “we,” “our,” and “us” in this Quarterly Report on

Form 10-Q

refer to AstroNova, Inc. and its consolidated subsidiaries.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with the Company’s Annual Report on Form

10-K

for the fiscal year ended January 31, 2019.

The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Some of the more significant estimates relate to revenue recognition, the allowances for doubtful accounts, inventory valuation, income taxes, impairment of long-lived assets and goodwill, share-based compensation, accrued expenses, lease accounting and warranty reserves. Management’s estimates are based on the facts and circumstances available at the time estimates are made, historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters. Consequently, actual results could differ from those estimates.

Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year.

Certain amounts in the prior year financial statements have been reclassified to conform to the current year’s presentation.

Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

Summary of Significant Accounting Policies Update

9 Months Ended

Nov. 02, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies Update

Note 2 – Summary of Significant Accounting Policies Update

The accounting polices used in preparing the condensed consolidated financial statements in this Form

10-Q

are the same as those used in preparing the Consolidated Financial Statements for the year ended January 31, 2019, except for the change resulting from the adoption of Accounting Standard Codification Topic 842 (“ASC 842”), Leases. See Note 11 for further details related to the new lease accounting policy as a result of this adoption.

Recently Adopted Accounting Pronouncements

Leases

In February 2019, the Company adopted the guidance issued by the Financial Accounting Standards Board (“FASB”) related to leases. See Note 11 for further details related to this adoption, including policy and expanded disclosure requirements.

Recent Accounting Standards Not Yet Adopted

Internal-Use

Software

In August 2018, the FASB issued

Accounting Standards Update (“ASU’)

2018-15,

“Intangibles—Goodwill and

Other—Internal-Use

Software (Subtopic

350-40):

Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.” ASU

2018-15

reduces complexity for the accounting for costs of implementing a cloud computing service arrangement and aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain

internal-use

software (and hosting arrangements that include an internal use software license). This ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019 (Q1 fiscal 2021 for AstroNova), with early adoption permitted. Implementation should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company is currently evaluating the impact this new guidance will have on its consolidated financial statements.

Fair Value Measurement

In August 2018, the FASB issued ASU

2018-13, “Fair

Value Measurement (Topic 820), Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement.” ASU

2018-13

modifies the disclosure requirements for fair value measurements by removing, modifying or adding certain disclosures. This ASU is effective for annual periods beginning after December 15, 2019 including interim periods within those fiscal years (Q1 fiscal 2021 for AstroNova), with early adoption permitted. The provisions of ASU

2018-13

relating to changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. The remaining provisions should be applied retrospectively to all periods presented upon their effective date. The Company is currently evaluating the impact this new guidance will have on its consolidated financial statements and related disclosures.

No other new accounting pronouncements, issued or effective during the nine months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

Revenue Recognition

9 Months Ended

Nov. 02, 2019

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Note 3 – Revenue Recognition

We derive revenue from the sale of (i) hardware, including digital color label printers and specialty OEM printing systems, portable data acquisition systems and airborne printers used in the flight deck and cabin of military, commercial and business aircraft, (ii) related supplies required in the operation of the hardware, (iii) repairs and maintenance of hardware and (iv) service agreements.

Revenues disaggregated by primary geographic markets and major product types are as follows:

Primary geographical markets:


	Three Months Ended				Nine Months Ended
(In thousands)	November 2, 2019		October 27, 2018		November 2, 2019		October 27, 2018
United States	$	21,831	$	21,542	$	64,471	$	60,752
Europe		7,059		7,573		22,408		23,292
Asia		1,396		1,560		7,063		4,653
Canada		1,441		1,860		4,346		5,836
Central and South America		1,019		921		3,232		3,078
Other		572		740		1,447		1,879

Total Revenue	$	33,318	$	34,196	$	102,967	$	99,490

Major product types:


	Three Months Ended				Nine Months Ended
(In thousands)	November 2, 2019		October 27, 2018		November 2, 2019		October 27, 2018
Hardware	$	12,160	$	13,096	$	37,514	$	37,989
Supplies		17,655		18,107		55,463		52,690
Service and Other		3,503		2,993		9,990		8,811

Total Revenue	$	33,318	$	34,196	$	1 02,967	$	99,490

Contract Assets and Liabilities

We normally do not have contract assets, which are primarily unbilled accounts receivable that are conditional on something other than the passage of time. Our contract liabilities, which represent billings in excess of revenue recognized, are related to advanced billings for purchased service agreements and extended warranties and were $387,000 and $373,000 at November 2, 2019 and January 31, 2019, respectively, and are recorded as deferred revenue in the condensed consolidated balance sheet. The

Company recognized $279,000 of

revenue during the nine

month period

ended November 2, 2019

, related to

the deferred revenue balance at January 31, 2019.

Contract Costs

We recognize an asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that certain costs related to obtaining sales contracts for our aerospace printer products meet the requirement to be capitalized. These costs are deferred and amortized based on the forecasted number of units sold over the estimated benefit term, which was estimated to be approximately 10 years. The balance of these contract assets at January 31, 2019 was $903,000. During the

third quarter of the current year the Company recognized additional direct costs of $121,000. The Company amortized $82,000 of direct costs for the

nine month

s

ended November 2, 2019

and the balance of deferred incremental direct costs net of accumulated amortization at November 2, 2019 was $942,000, of which $117,000 is reported in other current assets and $825,000 is reported in other assets in the accompanying condensed consolidated balance sheet. The remaining contract costs are expected to be amortized over the estimated remaining period of benefit, which we currently estimate to be approximately

seven

years.

Net Income Per Common Share

9 Months Ended

Nov. 02, 2019

Earnings Per Share [Abstract]

Net Income Per Common Share

Note 4 – Net Income Per Common Share

Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of shares and, if dilutive, common equivalent shares, determined using the treasury stock method for stock options, restricted stock awards and restricted stock units outstanding during the period. A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:


	Three Months Ended				Nine Months Ended
	November 2, 2019		October 27, 2018		November 2, 2019		October 27, 2018
Weighted Average Common Shares Outstanding – Basic		7,046,803		6,924,554		7,012,595		6,858,365
Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units		151,795		242,074		259,840		197,760

Weighted Average Common Shares Outstanding – Diluted		7,198,598		7,166,628		7,272,435		7,056,125

For the three and nine months ended November 2, 2019, the diluted per share amounts do not reflect common equivalent shares outstanding of 238,477 and 206,592

,

respectively. For the three and nine months ended October 27, 2018, the diluted per share amounts do not reflect common equivalent shares outstanding of 228,600 and 333,175

,

respectively. These outstanding common equivalent shares were not included due to their anti-dilutive effect.

Intangible Assets

9 Months Ended

Nov. 02, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Note 5 – Intangible Assets

Intangible assets are as follows:


	November 2, 2019									January 31, 2019
(In thousands)	Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount
Miltope:
Customer Contract Relationships	$	3,100	$	(1,947	)	$	—	$	1,153	$	3,100	$	(1,723	)	$	—	$	1,377
RITEC:
Customer Contract Relationships		2,830		(988	)		—		1,842		2,830		(725	)		—		2,105
Non-Competition Agreement		950		(823	)		—		127		950		(681	)		—		269
TrojanLabel:
Existing Technology		2,327		(968	)		92		1,451		2,327		(711	)		140		1,756
Distributor Relations		937		(273	)		34		698		937		(200	)		56		793
Honeywell:
Customer Contract Relationships		27,243		(6,060	)		—		21,183		27,243		(3,869	)		—		23,374

Intangible Assets, net	$	37,387	$	(11,059	)	$	126	$	26,454	$	37,387	$	(7,909	)	$	196	$	29,674

There were no impairments to intangible assets during the periods ended November 2, 2019 and October 27, 2018. With respect to the acquired intangibles included in the table above, amortization expense of $1.1 million and $1.0 million has been included in the condensed consolidated statements of income for the three months ended November 2, 2019 and October 27, 2018, respectively. Amortization expense of $3.2 million and $3.1 million related to the above acquired intangibles has been included in the condensed consolidated statement of income for the nine months ended November 2, 2019 and October 27, 2018, respectively.

Estimated amortization expense for the next five fiscal years is as follows:


(In thousands)	Remaining 2020		2021		2022		2023		2024
Estimated amortization expense	$	1,050	$	4,071	$	3,983	$	3,978	$	3,975

Inventories

9 Months Ended

Nov. 02, 2019

Inventory Disclosure [Abstract]

Inventories

Note 6 – Inventories

Inventories are stated at the lower of cost

(first-in,

first-out)

and net realizable value and include material, labor and manufacturing overhead. The components of inventories are as follows:


(In thousands)	November 2, 2019			January 31, 2019
Materials and Supplies	$	21,116		$	17,517
Work-In-Process		1,586			1,633
Finished Goods		18,170			15,688

		40,872			34,838
Inventory Reserve		(5,278	)		(4,677	)

	$	35,594		$	30,161

Revolving Line of Credit

9 Months Ended

Nov. 02, 2019

Debt Disclosure [Abstract]

Revolving Line of Credit

Note 7 – Revolving Line of Credit

The Company has

a

revolving line of credit under its existing Credit Agreement with Bank of America. Revolving credit loans may be borrowed, at the Company’s option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Kroner. Amounts borrowed under the revolving credit facility bear interest at a rate

per annum

equal to, at the Company’s option, either (a) the LIBOR rate (or, in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.0% to 1.5% based on the Company’s consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal funds’ rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate or (iii) the LIBOR rate plus 1.00%, plus a margin that varies within a range of 0.0% to 0.5% based on the Company’s consolidated leverage ratio.

At November 2, 2019, $6.5 million has been drawn

on the revolving line of credit. The outstanding balance bears interest at a weighted average annual rate of 5.26% and $93,000 and $39,000 of interest has been incurred on this obligation and included in other expense in the accompanying condensed consolidated income statement for the nine month periods ended November 2, 2019

and October 27, 2018

, respectively.

At

November 2, 2019, there

was

$3.5 million available for borrowing under the revolving credit facility.

Following the completion of the third quarter of fiscal 2020, the Company entered into a Fourth Amendment to the Credit Agreement to, among other things, temporarily increase the revolving line of credit from $10.0 million to $17.5 million and modify certain of the financial covenants with which the Company must comply thereunder. For additional information on the amendment and the resulting changes to the terms of the agreement, see Note 17 – Subsequent Events.

The Company is required to pay a commitment fee on the undrawn portion of the revolving credit facility at the rate of 0.25%

per annum

.

Debt

9 Months Ended

Nov. 02, 2019

Debt Disclosure [Abstract]

Debt

Note 8 – Debt

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:


(In thousands)	November 2, 2019			January 31, 2019
USD Term Loan (3.30% as of November 2, 2019 and 4.02% as of January 31, 2019); maturity date of November 20, 2022	$	9,000		$	11,250
USD Term Loan (3.30% as of November 2, 2019 and 4.02% as of January 31, 2019); maturity date of January 31, 2022		5,244			6,992

	$	14,244		$	18,242
Debt Issuance Costs, net of accumulated amortization		(124	)		(164	)
Current Portion of Term Loans		(5,116	)		(5,208	)

Long-Term Debt	$	9,004		$	12,870

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of November 2, 2019 is as follows:


(In thousands)
Fiscal 2020, remainder	$	1,210
Fiscal 2021		5,208
Fiscal 2022		5,576
Fiscal 2023		2,250
Fiscal 2024		—

	$	14,244

Following the completion of the third quarter of fiscal 2020, the Company entered into a Fourth Amendment to its Credit Agreement with Bank of America governing the Company’s long-term debt. Refer to Note 17 – Subsequent Events for additional information on the Fourth Amendment and the resulting changes to the terms of the

Credit

A

greement.

Derivative Financial Instruments and Risk Management

9 Months Ended

Nov. 02, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments and Risk Management

Note 9 – Derivative Financial Instruments and Risk Management

The Company has entered into a cross-currency interest rate swap to manage the interest rate risk and foreign currency exchange risk associated with the floating-rate foreign currency-denominated term loan borrowing by our Danish Subsidiary and an interest rate swap to manage the interest rate risk associated with the variable rate term loan borrowing by the Company. Both swaps have been designated as cash flow hedges of floating-rate borrowings.

The cross-currency interest rate swap agreement utilized by the Company effectively modifies the Company’s exposure to interest rate risk and foreign currency exchange rate risk by converting the Company’s floating-rate debt denominated in U.S. Dollars on our Danish subsidiary’s books to a fixed-rate debt denominated in Danish Kroner for the term of the loan, thus reducing the impact of interest-rate and foreign currency exchange rate changes on future interest expense and principal repayments. This swap involves the receipt of floating rate amounts in U.S. Dollars in exchange for fixed-rate interest payments in Danish Kroner, as well as exchanges of principal at the inception spot rate, over the life of the term loan.

The interest rate swap agreement utilized by the Company on its term loan effectively modifies the Company’s exposure to interest rate risk by converting the Company’s floating-rate debt to fixed-rate debt for the next five years, thus reducing the impact of interest-rate changes on future interest expense. This swap involves the receipt of floating rate amounts in U.S. Dollars in exchange for fixed rate payments in U.S. dollars over the life of the term loan.

The following table summarizes the notional amount and fair value of the Company’s derivative instrument:


Cash Flow Hedges	November 2, 2019						January 31, 2019
(In thousands)			Fair Value Derivatives						Fair Value Derivatives
	Notional Amount		Asset		Liability		Notional Amount		Asset		Liability
Cross-currency Interest Rate Swap	$	4,949	$	—	$	329	$	6,329	$	—	$	600
Interest Rate Swap	$	9,000	$	—	$	88	$	11,250	$	85	$	—

The following table presents the impact of the Company’s derivative instruments in our condensed consolidated financial statements for the three and

nine

months ended November 2, 2019 and October 27, 2018:


	Three Months Ended
	Amount of Gain (Loss) Recognized in OCI on Derivative				Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Expense)	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Expense)
Cash Flow Hedge (In thousands)	November 2, 2019		October 27, 2018			November 2, 2019			October 27, 2018
Swap Contracts	$	80	$	283	Other Income (Expense)	$	(3	)	$	192


	Nine Months Ended
	Amount of Gain (Loss) Recognized in OCI on Derivative				Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Expense)	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Expense)
Cash Flow Hedge (In thousands)	November 2, 2019		October 27, 2018			November 2, 2019		October 27, 2018
Swap Contracts	$	82	$	981	Other Income (Expense)	$	259	$	775

At November 2, 2019, the Company expects to reclassify approximately $0.2 million of net gains on the swap contracts from accumulated other comprehensive loss to earnings during the next 12 months due to changes in foreign exchange rates and the payment of variable interest associated with the floating-rate debt.

Royalty Obligation

9 Months Ended

Nov. 02, 2019

Royalty Obligation Disclosure [Abstract]

Royalty Obligation

Note 10 – Royalty Obligation

In fiscal 2018, AstroNova, Inc. entered into an Asset Purchase and License Agreement

(the “Honeywell Agreement”)

with Honeywell International, Inc. (“Honeywell”) to acquire an exclusive, perpetual, world-wide license to manufacture Honeywell’s narrow-format flight deck printers for two aircraft families along with certain inventory used in the manufacturing of the licensed printers. The purchase price included a guaranteed minimum royalty payment of $15.0 million, to be paid over ten years

. Royalty payments are

based on gross revenues from the sales of the printers, paper and repair services of the licensed products. The royalty rates vary based on the year in which they are paid or earned and product sold or service provided, and range from single-digit to mid double-digit percentages of gross revenue.

The guaranteed minimum royalty payment obligation was recorded at the present value of the minimum annual royalty payments using a present value factor of 2.8%, which is based on the estimated

after-tax

cost of debt for similar companies. As of November 2, 2019, the Company had paid an aggregate of $3.0 million of the guaranteed minimum royalty obligation. At November 2, 2019, the current portion of the outstanding guaranteed minimum royalty obligation of $2.0 million is to be paid over the next twelve months and is reported as a current liability and the remainder of $8.5 million is reported as a long-term liability on the Company’s condensed consolidated balance sheet. In addition to the guaranteed minimum royalty payments, the Company also incurred excess royalty expense of $0.1 million and $0.8 million, respectively, for the three and nine month periods ended November 2, 2019 and $0.7

million

and $2.0 million, respectively, for the three and nine month periods ended October 27, 2018 which is included in cost of revenue in the Company’s

condensed

consolidated statements of income. A total of $0.4 million of excess royalty is payable and reported as a current liability on the Company’s condensed consolidated balance sheet at November 2, 2019.

Leases

9 Months Ended

Nov. 02, 2019

Leases [Abstract]

Leases

Note 11 – Leases

Policy

On February 1, 2019 the Company adopted ASC 842, Leases. This new guidance requires a lessee to recognize assets and liabilities on the balance sheet for all leases, with the result being the recognition of a right of use (ROU) asset and a lease liability. The lease liability is equal to the present value of the minimum lease payments for the term of the lease, including any optional renewal periods determined to be reasonably certain to be exercised, using a discount rate determined at lease commencement. This discount rate is the rate implicit in the lease, if known; otherwise, the incremental borrowing rate for the expected lease term is used. The Company’s incremental borrowing rate approximates the rate the Company would have to pay to borrow on a collateralized basis over a similar term at lease inception. The value of the ROU asset is equal to the initial measurement of the lease liability plus any lease payments made to the lessor at or before the commencement date and any unamortized initial direct costs incurred by the lessee, less any unamortized lease incentives received.

There are two types of leases, operating leases and finance leases. Lease classification is determined at lease commencement. All of the Company’s leases are classified as operating leases. Operating lease expense is recognized on a straight-line basis over the lease term and included in general and administrative expense on the condensed consolidated statement of income. For operating leases, ROU assets are classified in other long-term assets, short-term lease liabilities are classified in other current liabilities, and long-term lease liabilities are classified in other long-term liabilities on the condensed consolidated balance sheet. On the cash flow statement, payments for operating leases are classified as operating activities.

The Company enters into lease contracts for certain of its facilities at various locations worldwide. At inception of a contract, the Company determines whether the contract is or contains a lease. If the Company has a right to obtain substantially all of the economic benefits from the use of the identified asset and the right to direct the use of the asset, then the contract contains a lease. Several of the Company’s lease contracts include options to extend the lease term and

the

Company includes the renewal options for these leases in the determination of the ROU asset and lease liability when the likelihood of renewal is determined to be reasonably certain.

In addition, several of our lease agreements include

non-lease

components for items such as common area maintenance and utilities which are accounted for separately from the lease component.

Adoption Method and Impact

The Company applied ASC 842 to all leases in effect at February 1, 2019 and adopted the accounting standard using the

non-comparative

transition option, which does not require the restatement of prior years. Comparative information has not been adjusted and continues to be reported under the previous accounting guidance. The Company has elected the package of practical expedients, which allows entities to not reassess (1) whether contracts are or contain leases, (2) lease classification and (3) initial direct costs. The Company has made an accounting policy election to apply the short-term exception, which does not require the capitalization of leases with terms of 12 months or less. On February 1, 2019, the Company recognized $2.0 million of ROU assets and lease liabilities on its consolidated balance sheet. The adoption did not have a material impact on the Company’s results of operations or cash flows.

Disclosure

Our leases have remaining lease terms of 1 to 12 years, some of which include options to extend the lease term for periods up to five years when it is reasonably certain the Company will exercise such options.

The company leases office space from an affiliate. This lease is classified as an operating lease with annual rental payments of approximately $64,000 and $66,000 in fiscal 2020 and 2021, respectively.

Balance sheet and other information related to our leases is as follows:


Operating Leases (In thousands)	Balance Sheet Classification	November 2, 2019
Lease Assets	Right of Use Assets	$	1,767
Lease Liabilities – Current	Other Liabilities and Accrued Expenses		429
Lease Liabilities – Long Term	Lease Liabilities		1,350

Lease cost information is as follows:


		Three Months Ended		Nine Months Ended
Operating Leases (In thousands)	Statement of Income Classification	November 2, 2019		November 2, 2019
Operating Lease Costs	General and Administrative Expense	$	119	$	329

Maturities of operating lease liabilities are as follows:


(In thousands)	November 2, 2019
2020	$	94
2021		420
2022		354
2023		302
2024		275
Thereafter		564

Total Lease Payments		2,009
Less: Imputed Interest		(230	)

Total Lease Liabilities	$	1,779

As of November 2, 2019, the weighted-average remaining lease term and weighted-average discount rate for our operating leases are 5.7 years and 3.98%, respectively. We calculated the weighted-average discount rate using incremental borrowing rates, which equal the rates of interest that we would pay to borrow funds on a fully collateralized basis over a similar term.

Supplemental cash flow information related to leases is as follows:


	Three Months Ended		Nine Months Ended
(In thousands)	November 2, 2019		November 2, 2019
Cash paid for amounts included in the measurement of lease liabilities:	$	108	$	306

As previously disclosed in our fiscal year 2019 Annual Report on Form

10-K

and under the previous lease accounting standard, future minimum operating lease commitments that had initial or remaining

non-cancelable

lease terms in excess of one year at January 31, 2019 were as follows:


(In thousands)
2020	$	574
2021		520
2022		387
2023		294
2024		273
Thereafter		568

	$	2,616

Accumulated Other Comprehensive Loss

9 Months Ended

Nov. 02, 2019

Equity [Abstract]

Accumulated Other Comprehensive Loss

Note 12 – Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss (“AOCL”) by component are as follows:


(In thousands)	Foreign Currency Translation Adjustments			Cash Flow Hedges			Total
Balance at January 31, 2019	$	(852	)	$	34		$	(818	)
Other Comprehensive Loss before reclassification		(166	)		62			(104	)
Amounts reclassified from AOCL to Earnings		0			(201	)		(201	)

Other Comprehensive Loss		(166	)		(139	)		(305	)

Balance at November 2, 2019	$	(1,018	)	$	(105	)	$	(1,123	)

The amounts presented above in other comprehensive loss are net of taxes except for translation adjustments associated with our German and Danish subsidiaries.

Share-Based Compensation

9 Months Ended

Nov. 02, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation

Note 13 – Share-Based Compensation

We have one equity incentive plan from which we are authorized to grant equity awards, the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards, including incentive stock options,

non-qualified

stock options, stock appreciation rights, time or performance-based restricted stock unit

s

(PSUs), restricted stock units (RSUs) and restricted stock awards (RSAs). At

our

annual meeting of shareholders

held

on June 4, 2019, the 2018 Plan was amended to increase the number of shares of the Company’s common stock available for issuance by 300,000, bringing the total number of shares available for issuance under the 2018 Plan from 650,000 to 950,000, plus an additional number of shares equal to the number of shares subject to awards granted under previous equity incentive plans that are forfeited, cancelled, satisfied without the issuance of stock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to any unvested award, reacquired by the Company at not more than the grantee’s purchase price (other than by exercise). Under the 2018 Plan, all awards to employees generally have a minimum vesting period of one year. Options granted under the 2018 Plan must be issued at an exercise price of not less than the fair market value of the Company’s common stock on the date of grant and expire after ten years. As of November 2, 2019, 161,375 unvested shares of restricted stock and options to purchase an aggregate of 146,000 shares were outstanding under the 2018 Plan.

In addition to the 2018 Plan, we previously granted equity awards under our 2015 Equity Incentive Plan (the “2015 Plan”) and our 2007 Equity Incentive Plan (the “2007 Plan”). Both the 2007 Plan and the 2015 Plan have expired and no new awards may be issued under either, but outstanding awards will continue to be governed by those plans. As of November 2, 2019, 1,007 unvested shares of restricted stock and options to purchase an aggregate of 376,645 shares were outstanding under the 2007 Plan and 27,527 unvested shares of restricted stock and options to purchase an aggregate of 184,650 shares were outstanding under the 2015 Plan.

On January 31, 2019, the compensation committee of the Company’s board of directors adopted an Amended and Restated

Non-Employee

Director Annual Compensation Program (the “New Program”), which became effective as of February 1, 2019 and supersedes the prior program. Pursuant to the New Program, beginning with fiscal 2020, each

non-employee

director will automatically receive a grant of restricted stock on the date of their

re-election

to the Company’s board of directors. The number of whole shares to be granted will be equal to the number calculated by dividing the stock component of the director compensation amount determined by the compensation committee for that year by the fair market value of our stock on that day. The value of the restricted stock award for fiscal 2020 is $60,000. To account for the partial year beginning on February 1, 2019 and continuing through the 2019 annual meeting, and thereby provide for the alignment of the timing of annual grants of restricted stock under the New Program with the election of directors at the annual meeting, a total of 4,340 shares of restricted stock were granted to the

non-employee

directors on February 1, 2019. A total of 11,560 shares were awarded to the

non-employee

directors as compensation under the New Program in the second quarter of fiscal 2020. Other than the shares granted on February 1, 2019, which vested on June 1, 2019, shares of restricted stock granted under the New Program will become vested on the first anniversary of the date of grant, conditioned upon the recipient’s continued service on the Board through that date.

In March 2019, the Company granted 47,474 RSUs and 50,148 PSUs to certain key employees.

Share-based compensation expense was recognized as follows:


	Three Months Ended				Nine Months Ended
(In thousands)	November 2, 2019		October 27, 2018		November 2, 2019		October 27, 2018
Stock Options	$	148	$	215	$	487	$	571
Restricted Stock Awards and Restricted Stock Units		371		290		1,074		757
Employee Stock Purchase Plan		6		5		15		11

Total	$	525	$	510	$	1,576	$	1,339

Stock Options

There were

no

stock options granted during the nine months ended November 2, 2019. The fair value of stock options granted during the nine months ended October 27, 2018 were estimated using the following assumptions:


	Nine Months Ended
	October 27, 2018
Risk Free Interest Rate		2.6	%
Expected Volatility		39.3	%
Expected Life (in years)		9.0
Dividend Yield		1.5	%

There were

no

stock options granted during the three month period ended October 27, 2018. The weighted average fair value per share for stock options granted was

$7.41 during

the

nine month period ended October 27, 2018.

Aggregated information regarding stock option activity for the nine months ended November

2

, 2019 is summarized below:


	Number of Options			Weighted Average Exercise Price
Outstanding at January 31, 2019		771,145		$	14.30
Granted		—			—
Exercised		(55,175	)		11.68
Forfeited		(8,275	)		16.72
Canceled		(400	)		6.22

Outstanding at November 2, 2019		707,295		$	14.48

Set forth below is a summary of options outstanding at November 2, 2019:


Outstanding							Exercisable
Range of Exercise prices	Number of Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Number of Shares		Weighted- Average Exercise Price		Weighted Average Remaining Contractual Life
$ 5.00 - 10.00		55,881	$	7.97		2.4		55,881	$	7.97		2.4
$ 10.01 - 15.00		414,814	$	13.62		6.1		326,794	$	13.64		5.6
$ 15.01 - 20.00		236,600	$	17.53		8.1		112,795	$	17.08		7.8

		707,295	$	14.48		6.5		495,470	$	13.78		5.8

As of November 2, 2019, there was approximately $0.9 million of unrecognized compensation expense related to stock options which is expected to be recognized over a weighted average period of approximately 1.7 years.

Restricted Stock Units (“RSUs”), Performance Based Restricted Stock Units (“PSUs”) and Restricted Stock Awards (“RSAs”)

Aggregated information regarding RSU, PSU and RSA activity for the nine months ended November 2, 2019 is summarized below:


	RSUs, PSUs & RSAs			Weighted Average Grant Date Fair Value
Outstanding at January 31, 2019		133,667		$	13.99
Granted		113,522			20.16
Vested		(55,180	)		16.62
Forfeited		(2,100	)		19.45

Outstanding at November 2, 2019		189,909		$	16.85

As of November 2, 2019, there was approximately $2.5 million of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of 0.9 years.

Employee Stock Purchase Plan

AstroNova has an Employee Stock Purchase Plan allowing eligible employees to purchase shares of common stock at a 15% discount from fair value on the first or last day of an offering period, whichever is less. A total of 247,500 shares were reserved for issuance under this plan. During the nine months ended November 2, 2019 and October 27 2018, there were 5,441 and 3,912 shares, respectively, purchased under this plan. As of November 2, 2019, 28,412 shares remain available.

Income Taxes

9 Months Ended

Nov. 02, 2019

Income Tax Disclosure [Abstract]

Income Taxes

Note 14 – Income Taxes

The Company’s effective tax rates for the period are as follows:


	Three Months Ended			Nine Months Ended
Fiscal 2020		(118.2	) %		5.5	%
Fiscal 2019		22.3	%		23.4	%

The Company determines its estimated annual effective tax rate at the end of each interim period based on full-year forecasted

pre-tax

income and facts known at that time. The estimated annual effective tax rate is applied to the

year-to-date

pre-tax

income at the end of each interim period with the cumulative effect of any changes in the estimated annual effective tax rate being recorded in the fiscal quarter in which the change is determined. The tax effect of significant unusual items is reflected in the period in which they occur.

During the three months ended November 2, 2019, the Company recognized an income tax

benefit

of approximately $247,000. The effective tax rate in this period was directly impacted by 1) a reduction in forecasted operating results for our fiscal 2020 as compared to operating results forecasted at the end of our

second

quarter of fiscal 2020

,

2)

a $306,000

tax benefit related to the reversal of previously uncertain tax positions due to the finalization of an IRS audit and 3) an $18,000

t

ax benefit arising from windfall tax benefits related to the Company’s stock. During the three months ended October 27

,

2018, the Company recognized an income tax expense of approximately $407,000. The effective tax rate in this period was directly impacted by a $98,000 benefit arising from windfall tax benefits related to the Company’s stock.

During the nine months ended November 2, 2019, the Company recognized an income tax expense of approximately $182,000. The effective tax rate in this period was directly impacted by 1) a $359,000 tax benefit related to the

reversal of previously uncertain tax positions due to the finalization of an IRS audit and the

expiration of the statute of limitations on previously uncertain tax position

s

and 2) a $251,000 tax benefit arising from windfall tax benefits related to the Company’s stock. During the nine months ended October 27, 2018, the Company recognized an income tax expense of approximately $1,046,000. The effective tax rate in this period was directly impacted by a $210,000 benefit arising from windfall tax benefits related to the Company’s stock and a $78,000 tax benefit related to the expiration of the statute of limitations on a previously uncertain tax position.

The Company maintains a valuation allowance on some of its deferred tax assets in certain jurisdictions. A valuation allowance is required when, based upon an assessment of various factors, including recent operating loss history, anticipated future earnings, and prudent and reasonable tax planning strategies, it is more likely than not that some portion of the deferred tax assets will not be realized.

Unrecognized tax benefits represent the difference between tax positions taken or expected to be taken in a tax return and the benefits recognized for financial reporting purposes. As of November 2, 2019, the Company’s cumulative unrecognized tax benefits totaled $360,000 compared to $618,000 as of January 31, 2019. Besides the expiration of the statute of limitations on a previously uncertain tax position

and finalization of an IRS audit

, there were no other developments affecting unrecognized tax benefits during the quarter ended November 2, 2019.

Segment Information

9 Months Ended

Nov. 02, 2019

Segment Reporting [Abstract]

Segment Information

Note 15 – Segment Information

AstroNova reports two segments: Product Identification and Test & Measurement. The Company evaluates segment performance based on the segment profit before corporate expenses.

Summarized below are the Revenue and Segment Operating Profit for each reporting segment:


	Three Months Ended										Nine Months Ended
	Revenue				Segment Operating Profit						Revenue				Segment Operating Profit
(In thousands)	November 2, 2019		October 27, 2018		November 2, 2019			October 27, 2018			November 2, 2019		October 27, 2018		November 2, 2019			October 27, 2018
Product Identification	$	21,749	$	21,684	$	1,880		$	2,014		$	67,484	$	63,407	$	6,990		$	5,833
T&M		11,569		12,512		1,397			3,184			35,483		36,083		5,533			8,256

Total	$	33,318	$	34,196		3,277			5,198		$	102,967	$	99,490		12,523			14,089

Corporate Expenses						2,830			2,836							8,445			8,298

Operating Income						447			2,362							4,078			5,791
Other Expense, Net						(238	)		(538	)						(788	)		(1,320	)

Income Before Income Taxes						209			1,824							3,290			4,471
Income Tax (Benefit) Provision						(247	)		407							182			1,046

Net Income					$	456		$	1,417						$	3,108		$	3,425

Fair Value

9 Months Ended

Nov. 02, 2019

Fair Value Disclosures [Abstract]

Fair Value

Note 16 – Fair Value

Assets and Liabilities Recorded at Fair Value on a Recurring Basis

The following tables provide a summary of the financial assets and liabilities that are measured at fair value as of November 2, 2019 and January 31, 2019:


Assets measured at fair value:	Fair value measurement at November 2 , 2019								Fair value measurement at January 31, 2019
(In thousands)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Interest Rate Swap Contract (included in Other Assets)	$	—	$	—	$	—	$	—	$	—	$	85	$	—	$	85

Total Assets	$	—	$	—	$	—	$	—	$	—	$	85	$	—	$	85


Liabilities measured at fair value:	Fair value measurement at November 2, 2019								Fair value measurement at January 31, 2019
(In thousands)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Cross-Currency Interest Rate Swap Contract (included in Other Long-Term Liabilities)	$	—	$	329	$	—	$	329	$	—	$	600	$	—	$	600
Interest Rate Swap Contract (included in Other Long-Term Liabilities)		—		88		—		88		—		—		—		—
Earnout Liability (included in Other Long-Term Liabilities)		—		—		14		14		—		—		14		14

Total Liabilities	$	—	$	417	$	14	$	431	$	—	$	600	$	14	$	614

We use the market approach to measure fair value of our derivative instruments. Derivative instruments were measured at fair value using readily observable market inputs, such as quotations on interest rates and foreign exchange rates, and are classified as Level 2 because they are

over-the-counter

contracts with a bank counterparty that are not traded in an active market.

The fair value of the earnout liability incurred in connection with the Company’s acquisition of TrojanLabel was determined using the option approach methodology, which includes using significant inputs that are not observable in the market and therefore classified as Level 3. Key assumptions in estimating the fair value of the contingent consideration liability included (1) the estimated earnout targets over the next seven years, (2) the probability of success (achievement of the various contingent events) and (3) a risk-adjusted discount rate used to adjust the probability-weighted earnout payments to their present value. At each reporting period, the contingent consideration liability is recorded at its fair value with changes reflected in general and administrative expense in the condensed consolidated statements of operations. There was no change in the fair value of the earnout liability for the nine months ended November

2

, 2019.

Assets and Liabilities Not Recorded at Fair Value

The Company’s long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:


	November 2, 2019
	Fair Value Measurement								Carrying
(In thousands)	Level 1		Level 2		Level 3		Total		Value
Long-Term D ebt and related current maturities	$	—	$	—	$	14,545	$	14,545	$	14,244

	January 31, 2019
	Fair Value Measurement								Carrying
(In thousands)	Level 1		Level 2		Level 3		Total		Value
Long-Term D ebt and related current maturities	$	—	$	—	$	18,857	$	18,857	$	18,242

The fair value of the Company’s long-term debt, including the current portion, is estimated by discounting the future cash flows using current interest rates at which similar loans with the same maturities would be made to borrowers with similar credit ratings and is classified as Level 3.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Subsequent Event

9 Months Ended

Nov. 02, 2019

Subsequent Events [Abstract]

Subsequent Event

Note 17 – Subsequent Event

On December 9, 2019, the Company and its wholly owned Danish subsidiaries, ANI ApS and TrojanLabel ApS (the “Parties”), entered into a Fourth Amendment (the “Fourth Amendment”) to the Credit Agreement dated as of February 28, 2017 between the Parties and Bank of America, N.A. (as previously amended, the “Credit Agreement”). The Fourth Amendment, which became effective as of November 30, 2019, amends the Credit Agreement to, among other things, (i) increase the aggregate amount available for borrowings under the revolving line of credit prior to November 1, 2020 from $10.0 million to $17.5 million and (ii) modify the financial covenants with which the Company must comply thereunder by excluding certain capital expenditures from the calculation of the Company’s consolidated fixed charge coverage ratio, providing that the minimum consolidated fixed charge coverage ratio covenant will be suspended through the second quarter of fiscal 2021, and adding a minimum consolidated EBITDA covenant commencing with the fourth quarter of fiscal 2020 and continuing through the second quarter of fiscal 2021.

Summary of Significant Accounting Policies Update (Policies)

9 Months Ended

Nov. 02, 2019

Accounting Policies [Abstract]

Leases

On February 1, 2019 the Company adopted ASC 842, Leases. This new guidance requires a lessee to recognize assets and liabilities on the balance sheet for all leases, with the result being the recognition of a right of use (ROU) asset and a lease liability. The lease liability is equal to the present value of the minimum lease payments for the term of the lease, including any optional renewal periods determined to be reasonably certain to be exercised, using a discount rate determined at lease commencement. This discount rate is the rate implicit in the lease, if known; otherwise, the incremental borrowing rate for the expected lease term is used. The Company’s incremental borrowing rate approximates the rate the Company would have to pay to borrow on a collateralized basis over a similar term at lease inception. The value of the ROU asset is equal to the initial measurement of the lease liability plus any lease payments made to the lessor at or before the commencement date and any unamortized initial direct costs incurred by the lessee, less any unamortized lease incentives received.

There are two types of leases, operating leases and finance leases. Lease classification is determined at lease commencement. All of the Company’s leases are classified as operating leases. Operating lease expense is recognized on a straight-line basis over the lease term and included in general and administrative expense on the condensed consolidated statement of income. For operating leases, ROU assets are classified in other long-term assets, short-term lease liabilities are classified in other current liabilities, and long-term lease liabilities are classified in other long-term liabilities on the condensed consolidated balance sheet. On the cash flow statement, payments for operating leases are classified as operating activities.

The Company enters into lease contracts for certain of its facilities at various locations worldwide. At inception of a contract, the Company determines whether the contract is or contains a lease. If the Company has a right to obtain substantially all of the economic benefits from the use of the identified asset and the right to direct the use of the asset, then the contract contains a lease. Several of the Company’s lease contracts include options to extend the lease term and

the

Company includes the renewal options for these leases in the determination of the ROU asset and lease liability when the likelihood of renewal is determined to be reasonably certain.

In addition, several of our lease agreements include

non-lease

components for items such as common area maintenance and utilities which are accounted for separately from the lease component.

Recent Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Leases

In February 2019, the Company adopted the guidance issued by the Financial Accounting Standards Board (“FASB”) related to leases. See Note 11 for further details related to this adoption, including policy and expanded disclosure requirements.

Recent Accounting Standards Not Yet Adopted

Internal-Use

Software

In August 2018, the FASB issued

Accounting Standards Update (“ASU’)

2018-15,

“Intangibles—Goodwill and

Other—Internal-Use

Software (Subtopic

350-40):

Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.” ASU

2018-15

reduces complexity for the accounting for costs of implementing a cloud computing service arrangement and aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain

internal-use

software (and hosting arrangements that include an internal use software license). This ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019 (Q1 fiscal 2021 for AstroNova), with early adoption permitted. Implementation should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company is currently evaluating the impact this new guidance will have on its consolidated financial statements.

Fair Value Measurement

In August 2018, the FASB issued ASU

2018-13, “Fair

Value Measurement (Topic 820), Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement.” ASU

2018-13

modifies the disclosure requirements for fair value measurements by removing, modifying or adding certain disclosures. This ASU is effective for annual periods beginning after December 15, 2019 including interim periods within those fiscal years (Q1 fiscal 2021 for AstroNova), with early adoption permitted. The provisions of ASU

2018-13

relating to changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. The remaining provisions should be applied retrospectively to all periods presented upon their effective date. The Company is currently evaluating the impact this new guidance will have on its consolidated financial statements and related disclosures.

No other new accounting pronouncements, issued or effective during the nine months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

Revenue Recognition (Tables)

9 Months Ended

Nov. 02, 2019

Revenue from Contract with Customer [Abstract]

Summary of Revenues Disaggregated by Primary Geographic Markets and Major Product Type

Revenues disaggregated by primary geographic markets and major product types are as follows:

Primary geographical markets:


	Three Months Ended				Nine Months Ended
(In thousands)	November 2, 2019		October 27, 2018		November 2, 2019		October 27, 2018
United States	$	21,831	$	21,542	$	64,471	$	60,752
Europe		7,059		7,573		22,408		23,292
Asia		1,396		1,560		7,063		4,653
Canada		1,441		1,860		4,346		5,836
Central and South America		1,019		921		3,232		3,078
Other		572		740		1,447		1,879

Total Revenue	$	33,318	$	34,196	$	102,967	$	99,490

Major product types:


	Three Months Ended				Nine Months Ended
(In thousands)	November 2, 2019		October 27, 2018		November 2, 2019		October 27, 2018
Hardware	$	12,160	$	13,096	$	37,514	$	37,989
Supplies		17,655		18,107		55,463		52,690
Service and Other		3,503		2,993		9,990		8,811

Total Revenue	$	33,318	$	34,196	$	1 02,967	$	99,490

Net Income Per Common Share (Tables)

9 Months Ended

Nov. 02, 2019

Earnings Per Share [Abstract]

Summary of Basic and Diluted Net Income Per Share

A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:


	Three Months Ended				Nine Months Ended
	November 2, 2019		October 27, 2018		November 2, 2019		October 27, 2018
Weighted Average Common Shares Outstanding – Basic		7,046,803		6,924,554		7,012,595		6,858,365
Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units		151,795		242,074		259,840		197,760

Weighted Average Common Shares Outstanding – Diluted		7,198,598		7,166,628		7,272,435		7,056,125

Intangible Assets (Tables)

9 Months Ended

Nov. 02, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Fair Value of Acquired Identifiable Intangible Assets and Related Estimated Useful Lives

Intangible assets are as follows:


	November 2, 2019									January 31, 2019
(In thousands)	Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Currency Translation Adjustment		Net Carrying Amount
Miltope:
Customer Contract Relationships	$	3,100	$	(1,947	)	$	—	$	1,153	$	3,100	$	(1,723	)	$	—	$	1,377
RITEC:
Customer Contract Relationships		2,830		(988	)		—		1,842		2,830		(725	)		—		2,105
Non-Competition Agreement		950		(823	)		—		127		950		(681	)		—		269
TrojanLabel:
Existing Technology		2,327		(968	)		92		1,451		2,327		(711	)		140		1,756
Distributor Relations		937		(273	)		34		698		937		(200	)		56		793
Honeywell:
Customer Contract Relationships		27,243		(6,060	)		—		21,183		27,243		(3,869	)		—		23,374

Intangible Assets, net	$	37,387	$	(11,059	)	$	126	$	26,454	$	37,387	$	(7,909	)	$	196	$	29,674

Summary of Estimated Amortization Expense

Estimated amortization expense for the next five fiscal years is as follows:


(In thousands)	Remaining 2020		2021		2022		2023		2024
Estimated amortization expense	$	1,050	$	4,071	$	3,983	$	3,978	$	3,975

Inventories (Tables)

9 Months Ended

Nov. 02, 2019

Inventory Disclosure [Abstract]

Components of Inventories

Inventories are stated at the lower of cost

(first-in,

first-out)

and net realizable value and include material, labor and manufacturing overhead. The components of inventories are as follows:


(In thousands)	November 2, 2019			January 31, 2019
Materials and Supplies	$	21,116		$	17,517
Work-In-Process		1,586			1,633
Finished Goods		18,170			15,688

		40,872			34,838
Inventory Reserve		(5,278	)		(4,677	)

	$	35,594		$	30,161

Debt (Tables)

9 Months Ended

Nov. 02, 2019

Debt Disclosure [Abstract]

Schedule of Short Term and Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:


(In thousands)	November 2, 2019			January 31, 2019
USD Term Loan (3.30% as of November 2, 2019 and 4.02% as of January 31, 2019); maturity date of November 20, 2022	$	9,000		$	11,250
USD Term Loan (3.30% as of November 2, 2019 and 4.02% as of January 31, 2019); maturity date of January 31, 2022		5,244			6,992

	$	14,244		$	18,242
Debt Issuance Costs, net of accumulated amortization		(124	)		(164	)
Current Portion of Term Loans		(5,116	)		(5,208	)

Long-Term Debt	$	9,004		$	12,870

Schedule of Required Principal Payments Remaining on Short Term and Long Term Debt Outstanding

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of November 2, 2019 is as follows:


(In thousands)
Fiscal 2020, remainder	$	1,210
Fiscal 2021		5,208
Fiscal 2022		5,576
Fiscal 2023		2,250
Fiscal 2024		—

	$	14,244

Derivative Financial Instruments and Risk Management (Tables)

9 Months Ended

Nov. 02, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Summarizes the Notional Amount and Fair Value of the Derivative Instrument

The following table summarizes the notional amount and fair value of the Company’s derivative instrument:


Cash Flow Hedges	November 2, 2019						January 31, 2019
(In thousands)			Fair Value Derivatives						Fair Value Derivatives
	Notional Amount		Asset		Liability		Notional Amount		Asset		Liability
Cross-currency Interest Rate Swap	$	4,949	$	—	$	329	$	6,329	$	—	$	600
Interest Rate Swap	$	9,000	$	—	$	88	$	11,250	$	85	$	—

Schedule of Impact of the Derivative Instruments in the Condensed Consolidated Financial Statements

The following table presents the impact of the Company’s derivative instruments in our condensed consolidated financial statements for the three and

nine

months ended November 2, 2019 and October 27, 2018:


	Three Months Ended
	Amount of Gain (Loss) Recognized in OCI on Derivative				Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Expense)	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Expense)
Cash Flow Hedge (In thousands)	November 2, 2019		October 27, 2018			November 2, 2019			October 27, 2018
Swap Contracts	$	80	$	283	Other Income (Expense)	$	(3	)	$	192


	Nine Months Ended
	Amount of Gain (Loss) Recognized in OCI on Derivative				Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Expense)	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Expense)
Cash Flow Hedge (In thousands)	November 2, 2019		October 27, 2018			November 2, 2019		October 27, 2018
Swap Contracts	$	82	$	981	Other Income (Expense)	$	259	$	775

Leases (Tables)

9 Months Ended

Nov. 02, 2019

Leases [Abstract]

Schedule Of Balance Sheet And Other Information Related To Operating Leases

Balance sheet and other information related to our leases is as follows:


Operating Leases (In thousands)	Balance Sheet Classification	November 2, 2019
Lease Assets	Right of Use Assets	$	1,767
Lease Liabilities – Current	Other Liabilities and Accrued Expenses		429
Lease Liabilities – Long Term	Lease Liabilities		1,350

Schedule Lease Cost Information

Lease cost information is as follows:


		Three Months Ended		Nine Months Ended
Operating Leases (In thousands)	Statement of Income Classification	November 2, 2019		November 2, 2019
Operating Lease Costs	General and Administrative Expense	$	119	$	329

Schedule of Maturities Of Lease Liabilities

Maturities of operating lease liabilities are as follows:


(In thousands)	November 2, 2019
2020	$	94
2021		420
2022		354
2023		302
2024		275
Thereafter		564

Total Lease Payments		2,009
Less: Imputed Interest		(230	)

Total Lease Liabilities	$	1,779

Supplemental Cash Flow Information Related To Leases

Supplemental cash flow information related to leases is as follows:


	Three Months Ended		Nine Months Ended
(In thousands)	November 2, 2019		November 2, 2019
Cash paid for amounts included in the measurement of lease liabilities:	$	108	$	306

Schedule Of Future Minimum Rental Payments For Operating Leases

As previously disclosed in our fiscal year 2019 Annual Report on Form

10-K

and under the previous lease accounting standard, future minimum operating lease commitments that had initial or remaining

non-cancelable

lease terms in excess of one year at January 31, 2019 were as follows:


(In thousands)
2020	$	574
2021		520
2022		387
2023		294
2024		273
Thereafter		568

	$	2,616

Accumulated Other Comprehensive Loss (Tables)

9 Months Ended

Nov. 02, 2019

Equity [Abstract]

Changes in Balance of Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss (“AOCL”) by component are as follows:


(In thousands)	Foreign Currency Translation Adjustments			Cash Flow Hedges			Total
Balance at January 31, 2019	$	(852	)	$	34		$	(818	)
Other Comprehensive Loss before reclassification		(166	)		62			(104	)
Amounts reclassified from AOCL to Earnings		0			(201	)		(201	)

Other Comprehensive Loss		(166	)		(139	)		(305	)

Balance at November 2, 2019	$	(1,018	)	$	(105	)	$	(1,123	)

Share-Based Compensation (Tables)

9 Months Ended

Nov. 02, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation Expense

Share-based compensation expense was recognized as follows:


	Three Months Ended				Nine Months Ended
(In thousands)	November 2, 2019		October 27, 2018		November 2, 2019		October 27, 2018
Stock Options	$	148	$	215	$	487	$	571
Restricted Stock Awards and Restricted Stock Units		371		290		1,074		757
Employee Stock Purchase Plan		6		5		15		11

Total	$	525	$	510	$	1,576	$	1,339

Fair Value of Stock Options Granted

There were no stock options granted during the nine months ended November 2, 2019. The fair value of stock options granted during the nine months ended October 27, 2018 were estimated using the following assumptions:


	Nine Months Ended
	October 27, 2018
Risk Free Interest Rate		2.6	%
Expected Volatility		39.3	%
Expected Life (in years)		9.0
Dividend Yield		1.5	%

Aggregated Information Regarding Stock Options Granted

Aggregated information regarding stock option activity for the nine months ended November

2

, 2019 is summarized below:


	Number of Options			Weighted Average Exercise Price
Outstanding at January 31, 2019		771,145		$	14.30
Granted		—			—
Exercised		(55,175	)		11.68
Forfeited		(8,275	)		16.72
Canceled		(400	)		6.22

Outstanding at November 2, 2019		707,295		$	14.48

Summary of Options Outstanding

Set forth below is a summary of options outstanding at November 2, 2019:


Outstanding							Exercisable
Range of Exercise prices	Number of Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Number of Shares		Weighted- Average Exercise Price		Weighted Average Remaining Contractual Life
$ 5.00 - 10.00		55,881	$	7.97		2.4		55,881	$	7.97		2.4
$ 10.01 - 15.00		414,814	$	13.62		6.1		326,794	$	13.64		5.6
$ 15.01 - 20.00		236,600	$	17.53		8.1		112,795	$	17.08		7.8

		707,295	$	14.48		6.5		495,470	$	13.78		5.8

Aggregated Information Regarding RSUs and RSAs Granted

Aggregated information regarding RSU, PSU and RSA activity for the nine months ended November 2, 2019 is summarized below:


	RSUs, PSUs & RSAs			Weighted Average Grant Date Fair Value
Outstanding at January 31, 2019		133,667		$	13.99
Granted		113,522			20.16
Vested		(55,180	)		16.62
Forfeited		(2,100	)		19.45

Outstanding at November 2, 2019		189,909		$	16.85

Income Taxes (Tables)

9 Months Ended

Nov. 02, 2019

Income Tax Disclosure [Abstract]

Projected Effective Tax Rate for Periods

The Company’s effective tax rates for the period are as follows:


	Three Months Ended			Nine Months Ended
Fiscal 2020		(118.2	) %		5.5	%
Fiscal 2019		22.3	%		23.4	%

Segment Information (Tables)

9 Months Ended

Nov. 02, 2019

Segment Reporting [Abstract]

Net Sales and Segment Operating Profit for Each Reporting Segment

Summarized below are the Revenue and Segment Operating Profit for each reporting segment:


	Three Months Ended										Nine Months Ended
	Revenue				Segment Operating Profit						Revenue				Segment Operating Profit
(In thousands)	November 2, 2019		October 27, 2018		November 2, 2019			October 27, 2018			November 2, 2019		October 27, 2018		November 2, 2019			October 27, 2018
Product Identification	$	21,749	$	21,684	$	1,880		$	2,014		$	67,484	$	63,407	$	6,990		$	5,833
T&M		11,569		12,512		1,397			3,184			35,483		36,083		5,533			8,256

Total	$	33,318	$	34,196		3,277			5,198		$	102,967	$	99,490		12,523			14,089

Corporate Expenses						2,830			2,836							8,445			8,298

Operating Income						447			2,362							4,078			5,791
Other Expense, Net						(238	)		(538	)						(788	)		(1,320	)

Income Before Income Taxes						209			1,824							3,290			4,471
Income Tax (Benefit) Provision						(247	)		407							182			1,046

Net Income					$	456		$	1,417						$	3,108		$	3,425

Fair Value (Tables)

9 Months Ended

Nov. 02, 2019

Fair Value Disclosures [Abstract]

Summary of Financial Assets and Liabilities Measured at Fair Value

The following tables provide a summary of the financial assets and liabilities that are measured at fair value as of November 2, 2019 and January 31, 2019:


Assets measured at fair value:	Fair value measurement at November 2 , 2019								Fair value measurement at January 31, 2019
(In thousands)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Interest Rate Swap Contract (included in Other Assets)	$	—	$	—	$	—	$	—	$	—	$	85	$	—	$	85

Total Assets	$	—	$	—	$	—	$	—	$	—	$	85	$	—	$	85


Liabilities measured at fair value:	Fair value measurement at November 2, 2019								Fair value measurement at January 31, 2019
(In thousands)	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Cross-Currency Interest Rate Swap Contract (included in Other Long-Term Liabilities)	$	—	$	329	$	—	$	329	$	—	$	600	$	—	$	600
Interest Rate Swap Contract (included in Other Long-Term Liabilities)		—		88		—		88		—		—		—		—
Earnout Liability (included in Other Long-Term Liabilities)		—		—		14		14		—		—		14		14

Total Liabilities	$	—	$	417	$	14	$	431	$	—	$	600	$	14	$	614

Schedule of Company's Long-Term Debt Including the Current Portion Not Reflected in Financial Statements at Fair Value

The Company’s long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:


	November 2, 2019
	Fair Value Measurement								Carrying
(In thousands)	Level 1		Level 2		Level 3		Total		Value
Long-Term D ebt and related current maturities	$	—	$	—	$	14,545	$	14,545	$	14,244

	January 31, 2019
	Fair Value Measurement								Carrying
(In thousands)	Level 1		Level 2		Level 3		Total		Value
Long-Term D ebt and related current maturities	$	—	$	—	$	18,857	$	18,857	$	18,242

Business and Basis of Presentation - Additional Information (Detail)	9 Months Ended
	Nov. 02, 2019 Segment
Number of Operating Segments	2

Revenue Recognition - Summary of Revenues Disaggregated by Primary Geographic Markets (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2019	Oct. 27, 2018	Nov. 02, 2019	Oct. 27, 2018
Disaggregation of Revenue [Line Items]
Total Revenue	$ 33,318	$ 34,196	$ 102,967	$ 99,490
United States [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	21,831	21,542	64,471	60,752
Europe [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	7,059	7,573	22,408	23,292
Canada [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	1,441	1,860	4,346	5,836
Asia [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	1,396	1,560	7,063	4,653
Central and South America [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	1,019	921	3,232	3,078
Other [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	$ 572	$ 740	$ 1,447	$ 1,879

Revenue Recognition - Summary of Revenues Disaggregated by Primary Product Type (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2019	Oct. 27, 2018	Nov. 02, 2019	Oct. 27, 2018
Disaggregation of Revenue [Line Items]
Total Revenue	$ 33,318	$ 34,196	$ 102,967	$ 99,490
Hardware [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	12,160	13,096	37,514	37,989
Supplies [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	17,655	18,107	55,463	52,690
Service and Other [Member]
Disaggregation of Revenue [Line Items]
Total Revenue	$ 3,503	$ 2,993	$ 9,990	$ 8,811

Revenue Recognition - Additional Information (Detail) - USD ($)	3 Months Ended	9 Months Ended
	Nov. 02, 2019	Nov. 02, 2019	Jan. 31, 2019
Disaggregation of Revenue [Abstract]
Contract liabilities and extended warranties	$ 387,000	$ 387,000	$ 373,000
Revenue recognized		279,000
Contract assets balance	825,000	825,000	$ 903,000
Amortization of incremental direct costs		82,000
Deferred incremental direct contract costs reported in other current assets	$ 117,000	$ 117,000
Amortization period of contract costs	7 years	7 years
Deferred incremental direct costs net of accumulated amortization	$ 942,000	$ 942,000
Capitalized Contract Costs Benefitial Term		10 years
Capitalised contract costs additionally incurred	$ 121,000

Net Income Per Common Share - Reconciliation of Shares Used in Calculating Basic and Diluted (Detail) - shares	3 Months Ended		9 Months Ended
	Nov. 02, 2019	Oct. 27, 2018	Nov. 02, 2019	Oct. 27, 2018
Weighted Average Common Shares Outstanding – Basic	7,047,000	6,925,000	7,013,000	6,858,000
Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units	151,795	242,074	259,840	197,760
Weighted Average Common Shares Outstanding – Diluted	7,199,000	7,167,000	7,272,000	7,056,000

Net Income Per Common Share - Additional Information (Detail) - shares	3 Months Ended		9 Months Ended
	Nov. 02, 2019	Oct. 27, 2018	Nov. 02, 2019	Oct. 27, 2018
Number of common equivalent shares	238,477	228,600	206,592	333,175

Intangible Assets - Fair Value of Acquired Identifiable Intangible Assets and Related Estimated Useful Lives (Detail) - USD ($) $ in Thousands	Nov. 02, 2019	Jan. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 37,387	$ 37,387
Accumulated Amortization	(11,059)	(7,909)
Currency Translation Adjustment	126	196
Net Carrying Amount	26,454	29,674
Customer Contract Relationships [Member] \| Honeywell Asset Purchase and License Agreement [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	27,243	27,243
Accumulated Amortization	(6,060)	(3,869)
Net Carrying Amount	21,183	23,374
Customer Contract Relationships [Member] \| Miltope [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	3,100	3,100
Accumulated Amortization	(1,947)	(1,723)
Net Carrying Amount	1,153	1,377
Customer Contract Relationships [Member] \| RITEC [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,830	2,830
Accumulated Amortization	(988)	(725)
Net Carrying Amount	1,842	2,105
Non-Competition Agreement [Member] \| RITEC [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	950	950
Accumulated Amortization	(823)	(681)
Net Carrying Amount	127	269
Existing Technology [Member] \| TrojanLabel ApS [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,327	2,327
Accumulated Amortization	(968)	(711)
Currency Translation Adjustment	92	140
Net Carrying Amount	1,451	1,756
Distributor Relations [Member] \| TrojanLabel ApS [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	937	937
Accumulated Amortization	(273)	(200)
Currency Translation Adjustment	34	56
Net Carrying Amount	$ 698	$ 793

Intangible Assets - Additional Information (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 02, 2019	Oct. 27, 2018	Nov. 02, 2019	Oct. 27, 2018
Impairment of Intangible Assets (Excluding Goodwill) [Abstract]
Impairments of intangible assets	$ 0	$ 0	$ 0	$ 0
Amortization expense	$ 1,100,000	$ 1,000,000	$ 3,200,000	$ 3,100,000

Intangible Assets - Summary of Estimated Amortization Expense (Detail) $ in Thousands	Nov. 02, 2019 USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2020	$ 1,050
2021	4,071
2022	3,983
2023	3,978
2024	$ 3,975

Inventories - Components of Inventories (Detail) - USD ($) $ in Thousands	Nov. 02, 2019	Jan. 31, 2019
Inventory Disclosure [Abstract]
Materials and Supplies	$ 21,116	$ 17,517
Work-In-Process	1,586	1,633
Finished Goods	18,170	15,688
Inventory, Gross	40,872	34,838
Inventory Reserve	(5,278)	(4,677)
Inventories	$ 35,594	$ 30,161

Revolving Credit Facility - Additional Information (Detail) - USD ($)	3 Months Ended	9 Months Ended
	Nov. 02, 2019	Nov. 02, 2019	Dec. 09, 2019	Jan. 31, 2019
Line of Credit Facility [Line Items]
Credit facility outstanding	$ 6,500,000	$ 6,500,000		$ 1,500,000
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Annual interest rate	5.26%	5.26%
Accrued interest expense	$ 93,000	$ 39,000
Credit facility, remaining borrowing capacity	3,500,000	$ 3,500,000
Commitment fee rate		0.25%
Revolving Credit Facility [Member] \| LIBOR [Member]
Line of Credit Facility [Line Items]
Interest rate		1.00%
Revolving Credit Facility [Member] \| Federal Funds Effective Swap Rate [Member]
Line of Credit Facility [Line Items]
Interest rate		0.50%
Revolving Credit Facility [Member] \| Minimum [Member]
Line of Credit Facility [Line Items]
Percentage added to variable rate		0.00%
Revolving Credit Facility [Member] \| Minimum [Member] \| LIBOR [Member]
Line of Credit Facility [Line Items]
Interest rate		1.00%
Revolving Credit Facility [Member] \| Maximum [Member]
Line of Credit Facility [Line Items]
Percentage added to variable rate		0.50%
Revolving Credit Facility [Member] \| Maximum [Member] \| LIBOR [Member]
Line of Credit Facility [Line Items]
Interest rate		1.50%
Third Amendment [Member] \| Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 10,000,000	$ 10,000,000
Fourth Amendment [Member] \| Revolving Credit Facility [Member] \| Subsequent Event [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity			$ 17,500,000

Debt - Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands	Nov. 02, 2019	Jan. 31, 2019
Debt Instrument [Line Items]
USD Term Loan	$ 14,244	$ 18,242
Debt Issuance Costs, net of accumulated amortization	(124)	(164)
Current Portion of Term Loans	(5,116)	(5,208)
Long-Term Debt	9,004	12,870
Term Loan Due November 20, 2022 [Member]
Debt Instrument [Line Items]
USD Term Loan	9,000	11,250
Term Loan Due January 31, 2022 [Member]
Debt Instrument [Line Items]
USD Term Loan	$ 5,244	$ 6,992

Debt - Schedule of Long Term Debt in the Accompanying Condensed Consolidated Balance Sheets (Parenthetical) (Detail)	9 Months Ended
	Nov. 02, 2019	Jan. 31, 2019
Debt Instrument [Line Items]
Debt instrument, description of variable rate basis	(3.30% as of November 2, 2019 and 4.02% as of January 31, 2019); maturity date of November 20, 2022
Term Loan Due November 20, 2022 [Member]
Debt Instrument [Line Items]
Debt instrument, maturity date	Nov. 20, 2022
Term Loan Due November 20, 2022 [Member] \| LIBOR [Member]
Debt Instrument [Line Items]
Interest rate	3.30%	4.02%
Term Loan Due January 31, 2022 [Member]
Debt Instrument [Line Items]
Debt instrument, maturity date	Jan. 31, 2022
Term Loan Due January 31, 2022 [Member] \| LIBOR [Member]
Debt Instrument [Line Items]
Debt instrument, description of variable rate basis	(3.30% as of November 2, 2019 and 4.02% as of January 31, 2019); maturity date of January 31, 2022
Interest rate	3.30%	4.02%

Debt - Schedule of Required Principal Payments Remaining on Long Term Debt Outstanding (Detail) - Term Loan [Member] $ in Thousands	Nov. 02, 2019 USD ($)
Debt Instrument [Line Items]
Fiscal 2020, remainder	$ 1,210
Fiscal 2021	5,208
Fiscal 2022	5,576
Fiscal 2023	2,250
Fiscal 2024
Long term debt	$ 14,244

Derivative Financial Instruments and Risk Management - Schedule of Impact of the Derivative Instruments in the Condensed Consolidated Financial Statements (Detail) - Cash Flow Hedge [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2019	Oct. 27, 2018	Nov. 02, 2019	Oct. 27, 2018	Jan. 31, 2019
Cross Currency Interest Rate Contract [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain Recognized in OCI on Derivative	$ 80	$ 283	$ 82	$ 981
Location of Gain Reclassified from Accumulated OCI into Income (Expense)	Other Income (Expense)		Other Income (Expense)
Amount of Gain Reclassified from Accumulated OCI into Income (Expense)	$ (3)	$ 192	$ 259	$ 775
Cross Currency Interest Rate Swap [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	4,949		4,949		$ 6,329
Fair Value Derivatives, Liability	329		329		600
Interest Rate Swap [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	9,000		9,000		11,250
Fair Value Derivatives, Asset					$ 85
Fair Value Derivatives, Liability	$ 88		$ 88

Derivative Financial Instruments and Risk Management - Additional Information (Detail) - Cross Currency Interest Rate Contract [Member] $ in Millions	9 Months Ended
	Nov. 02, 2019 USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Maximum remaining maturity of foreign currency derivatives	5 years
Amount of gain reclassify from Accumulated OCI into loss during next 12 months	$ 0.2

Royalty Obligation - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2019	Oct. 27, 2018	Nov. 02, 2019	Oct. 27, 2018	Jan. 31, 2019	Jan. 31, 2018
Guaranteed Minimum Royalty Payment			$ 3,000
Royalty Obligation, Current	$ 2,000		2,000		$ 1,875
Royalty Obligation Non Current	8,488		8,488		9,916
Accrued Royalties, Current, Excess Royalty Payment Due	419		$ 419		$ 1,265
Honeywell Asset Purchase and License Agreement [Member]
Payment Term Period			10 years
Minimum Royalty Payment Obligations						$ 15,000
Fair Value Assumption Percentage Of Present Value Factor			2.80%
Royalty Obligation, Current	2,000		$ 2,000
Royalty Obligation Non Current	8,500		8,500
Excess Royalty Payments	$ 100	$ 700	$ 800	$ 2,000

Leases - Additional Information (Detail) - USD ($)	9 Months Ended	12 Months Ended
Leases - Additional Information (Detail) - USD ($)	Nov. 02, 2019	Jan. 31, 2021	Jan. 31, 2020	Feb. 01, 2019
Lessee, Operating Lease, Option to Extend	options to extend the lease term for periods up to five years
Operating Lease, Weighted Average Remaining Lease Term	5 years 8 months 12 days
Operating Lease, Weighted Average Discount Rate, Percent	3.98%
Operating lease, right-of-use asset	$ 1,767,000
Operating lease liability	$ 1,779,000
Accounting Standards Update 2016-02 [Member]
Operating lease, right-of-use asset				$ 2,000,000
Operating lease liability				$ 2,000,000
Maximum [Member]
Operating Lease Remaining Lease Term	12 years
Minimum [Member]
Operating Lease Remaining Lease Term	1 year
Scenario, Forecast [Member]
Lease expense, related party		$ 66,000	$ 64,000

Leases - Schedule Of Balance Sheet And Other Information Related To Operating Leases (Detail) $ in Thousands	Nov. 02, 2019 USD ($)
Operating Leases [Abstract]
Right of Use Asset	$ 1,767
Other Liabilities and Accrued Expenses	429
Operating Lease Liabilities	$ 1,350

Leases - Lease Cost Information (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Nov. 02, 2019	Nov. 02, 2019
General and Administrative Expense [Member]
Operating Lease Costs	$ 119	$ 329

Leases - Maturities of lease liabilities (Detail) $ in Thousands	Nov. 02, 2019 USD ($)
Leases [Abstract]
2020	$ 94
2021	420
2022	354
2023	302
2024	275
Thereafter	564
Total Lease Payments	2,009
Less: Imputed Interest	(230)
Total Lease Liabilities	$ 1,779

Leases - Supplemental cash flow information (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Nov. 02, 2019	Nov. 02, 2019
Cash paid for amounts included in the measurement of lease liabilities [Abstract]
Operating cash flows for operating leases	$ 108	$ 306

Leases - Future minimum operating lease commitments (Detail) $ in Thousands	Jan. 31, 2019 USD ($)
2020	$ 574
2021	520
2022	387
2023	294
2024	273
Thereafter	568
Total	$ 2,616

Accumulated Other Comprehensive Loss - Changes in Balance of Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Nov. 02, 2019	Aug. 03, 2019	May 04, 2019	Oct. 27, 2018	Jul. 28, 2018	Apr. 28, 2018	Nov. 02, 2019	Nov. 02, 2019	Oct. 27, 2018
Schedule of Capitalization, Equity [Line Items]
Beginning Balance	$ 72,088	$ 71,614	$ 69,775	$ 65,488	$ 64,630	$ 63,647	$ 69,775	$ 69,775	$ 63,647
Other Comprehensive Income (Loss)	152	(257)	(200)	(86)	(362)	(163)		(305)	(611)
Ending Balance	72,953	72,088	71,614		65,488	64,630	72,953	72,953
Foreign Currency Translation Adjustments [Member]
Schedule of Capitalization, Equity [Line Items]
Beginning Balance							(852)
Other Comprehensive Loss before reclassification							(166)
Amounts reclassified from AOCL to Earnings							0
Other Comprehensive Income (Loss)							(166)
Ending Balance	(1,018)						(1,018)	(1,018)
Net Unrealized Gain/(Loss) on Cash Flow Hedges [Member]
Schedule of Capitalization, Equity [Line Items]
Beginning Balance							34
Other Comprehensive Loss before reclassification							62
Amounts reclassified from AOCL to Earnings							(201)
Other Comprehensive Income (Loss)							(139)
Ending Balance	(105)						(105)	(105)
Accumulated Other Comprehensive Income (Loss) [Member]
Schedule of Capitalization, Equity [Line Items]
Beginning Balance	(1,275)	(1,018)	(818)	(697)	(335)	(172)	(818)	(818)	$ (172)
Other Comprehensive Loss before reclassification							(104)
Amounts reclassified from AOCL to Earnings							(201)
Other Comprehensive Income (Loss)	152	(257)	(200)	$ (86)	(362)	(163)	(305)
Ending Balance	$ (1,123)	$ (1,275)	$ (1,018)		$ (697)	$ (335)	$ (1,123)	$ (1,123)

Share-Based Compensation - Additional Information (Detail) - USD ($)			1 Months Ended		3 Months Ended		9 Months Ended			12 Months Ended
	Jun. 04, 2019	Feb. 01, 2019	Mar. 31, 2019	Jan. 31, 2019	Nov. 02, 2019	Oct. 27, 2018	Nov. 02, 2019	Nov. 02, 2019	Oct. 27, 2018	Jan. 31, 2020	Aug. 03, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding		771,145			707,295		707,295	707,295
Reservation of shares under Stock Purchase Plan							247,500
Restricted Stock or Unit Expense					$ 371,000	$ 290,000	$ 1,074,000		$ 757,000
2015 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding					27,527		27,527	27,527
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee Stock Purchase Plan discount rate							15.00%
Shares purchase under Employee Stock Purchase Plan							5,441		3,912
Shares available for grant under the Plan					28,412		28,412	28,412
2007 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding					376,645		376,645	376,645
2018 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized for grant under the Plan	650,000										950,000
Number of shares outstanding					146,000		146,000	146,000
Additional Shares Authorized Under the Plan	300,000
Certain Key Employees [Member] \| 2018 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted			50,148
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted						0	0
Unrecognized compensation expense related to options					$ 900,000		$ 900,000	$ 900,000
Unrecognized compensation expense to be recognized, Weighted average period							1 year 8 months 12 days
Options granted weighted-average fair value per share									$ 7.41
2014 Restricted Stock Units (RSUs) [Member] \| Certain Key Employees [Member] \| 2018 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted			47,474
RSA [Member] \| 2015 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding					184,650		184,650	184,650
RSA [Member] \| 2007 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding					1,007		1,007	1,007
RSA [Member] \| 2018 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted				161,375
RSA [Member] \| Non-Employee Director [Member] \| 2018 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted		4,340
Restricted Stock Award [Member] \| Scenario, Forecast [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock or Unit Expense										$ 60,000
Restricted Stock Award [Member] \| New Program [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted								11,560
Restricted Stock Award And Restricted Stock Unit [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted							113,522
Unrecognized compensation expense related to options					$ 2,500,000		$ 2,500,000	$ 2,500,000
Unrecognized compensation expense to be recognized, Weighted average period							10 months 24 days

Share-Based Compensation - Share-Based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 02, 2019	Oct. 27, 2018	Nov. 02, 2019	Oct. 27, 2018
Share-based Compensation [Abstract]
Stock Options	$ 148	$ 215	$ 487	$ 571
Restricted Stock Awards and Restricted Stock Units	371	290	1,074	757
Employee Stock Purchase Plan	6	5	15	11
Total	$ 525	$ 510	$ 1,576	$ 1,339

Share-Based Compensation - Fair Value of Stock Options Granted (Detail)	9 Months Ended
	Oct. 27, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Risk-Free Interest Rate	2.60%
Expected Volatility	39.30%
Expected Life (in years)	9 years
Dividend Yield	1.50%

Share-Based Compensation - Aggregated Information Regarding Stock Options Granted (Detail)	9 Months Ended
	Nov. 02, 2019 $ / shares shares
Share-based Compensation [Abstract]
Beginning balance, Number of Options \| shares	771,145
Exercised, Number of Options \| shares	(55,175)
Forfeited, Number of Options \| shares	(8,275)
Canceled, Number of Options \| shares	(400)
Ending balance, Number of Options \| shares	707,295
Beginning balance, Weighted-Average Exercise Price \| $ / shares	$ 14.30
Exercised, Weighted-Average Exercise Price \| $ / shares	11.68
Forfeited, Weighted Average Exercise Price \| $ / shares	16.72
Cancelled, Weighted-Average Exercise Price Per Share \| $ / shares	6.22
Ending balance, Weighted-Average Exercise Price \| $ / shares	$ 14.48

Share-Based Compensation - Summary of Options Outstanding (Detail) - $ / shares	9 Months Ended
	Nov. 02, 2019	Feb. 01, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding, total	707,295	771,145
Outstanding, Weighted Average Exercise Price	$ 14.48
Exercisable, Weighted Average Exercise Price	$ 13.78
Outstanding Remaining Contractual Life	6 years 6 months
Number of shares exercisable, total	495,470
Exercisable Remaining Contractual Life	5 years 9 months 18 days
$5.00 - $10.00 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Range of Exercise prices, Lower Limit	$ 5.00
Outstanding Range of Exercise prices, Upper Limit	$ 10.00
Outstanding, Number of shares	55,881
Outstanding, Weighted Average Exercise Price	$ 7.97
Exercisable, Weighted Average Exercise Price	$ 7.97
Outstanding Remaining Contractual Life	2 years 4 months 24 days
Exercisable, Number of shares	55,881
Exercisable Remaining Contractual Life	2 years 4 months 24 days
$10.01 - $15.00 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Range of Exercise prices, Lower Limit	$ 10.01
Outstanding Range of Exercise prices, Upper Limit	$ 15.00
Outstanding, Number of shares	414,814
Outstanding, Weighted Average Exercise Price	$ 13.62
Exercisable, Weighted Average Exercise Price	$ 13.64
Outstanding Remaining Contractual Life	6 years 1 month 6 days
Exercisable, Number of shares	326,794
Exercisable Remaining Contractual Life	5 years 7 months 6 days
$15.01 - $20.00 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Range of Exercise prices, Lower Limit	$ 15.01
Outstanding Range of Exercise prices, Upper Limit	$ 20.00
Outstanding, Number of shares	236,600
Outstanding, Weighted Average Exercise Price	$ 17.53
Exercisable, Weighted Average Exercise Price	$ 17.08
Outstanding Remaining Contractual Life	8 years 1 month 6 days
Exercisable, Number of shares	112,795
Exercisable Remaining Contractual Life	7 years 9 months 18 days

Share-Based Compensation - Aggregated Information Regarding RSUs and RSAs Granted (Detail) - Restricted Stock Award And Restricted Stock Unit [Member]	9 Months Ended
	Nov. 02, 2019 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning balance, Outstanding Restricted Stock Units and Restricted Stock Awards \| shares	133,667
Granted, Restricted Stock Units and Restricted Stock Awards \| shares	113,522
Vested, Restricted Stock Units and Restricted Stock Awards \| shares	(55,180)
Forfeited, Restricted Stock Units and Restricted Stock Awards \| shares	(2,100)
Ending balance, Outstanding Restricted Stock Units and Restricted Stock Awards \| shares	189,909
Beginning balance, Weighted Average Grant Date Fair Value \| $ / shares	$ 13.99
Granted, Weighted Average Grant Date Fair Value \| $ / shares	20.16
Vested, Weighted Average Grant Date Fair Value \| $ / shares	16.62
Forfeited, Weighted Average Grant Date Fair Value \| $ / shares	19.45
Ending balance, Weighted Average Grant Date Fair Value \| $ / shares	$ 16.85

Income Taxes - Projected Effective Tax Rate for Periods (Detail)	3 Months Ended		9 Months Ended
	Nov. 02, 2019	Oct. 27, 2018	Nov. 02, 2019	Oct. 27, 2018
Income Tax Disclosure [Abstract]
Effective tax rates for income from continuing operations	(118.20%)	22.30%	5.50%	23.40%

Income Taxes - Additional Information (Detail) - USD ($)	3 Months Ended			9 Months Ended
	Nov. 02, 2019	Aug. 03, 2019	Oct. 27, 2018	Nov. 02, 2019	Oct. 27, 2018	Jan. 31, 2019
Income Tax Disclosure [Abstract]
Income tax expense	$ (247,000)		$ 407,000	$ 182,000	$ 1,046,000
Income tax benefit from windfall of stock		$ 306,000	18,000	251,000	78,000
Expiration of the statue of limitations on previously uncertain tax positions			$ 98,000	359,000	$ 210,000
Cumulative unrecognized tax benefits	360,000			$ 360,000		$ 618,000
Changes to unrecognized tax benefits	$ 0

Segment Information - Net Sales and Segment Operating Profit for Each Reporting Segment (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Nov. 02, 2019	Aug. 03, 2019	May 04, 2019	Oct. 27, 2018	Jul. 28, 2018	Apr. 28, 2018	Nov. 02, 2019	Oct. 27, 2018
Segment Reporting Information [Line Items]
Revenue	$ 33,318			$ 34,196			$ 102,967	$ 99,490
Corporate Expenses	2,830			2,836			8,445	8,298
Operating Income	447			2,362			4,078	5,791
Other Expense, Net	(238)			(538)			(788)	(1,320)
Income before Income Taxes	209			1,824			3,290	4,471
Income Tax (Benefit) Provision	(247)			407			182	1,046
Net Income	456	$ 951	$ 1,700	1,417	$ 1,194	$ 814	3,108	3,425
Product Identification [Member]
Segment Reporting Information [Line Items]
Revenue	21,749			21,684			67,484	63,407
T&M [Member]
Segment Reporting Information [Line Items]
Revenue	11,569			12,512			35,483	36,083
Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating Income	3,277			5,198			12,523	14,089
Operating Segments [Member] \| Product Identification [Member]
Segment Reporting Information [Line Items]
Operating Income	1,880			2,014			6,990	5,833
Operating Segments [Member] \| T&M [Member]
Segment Reporting Information [Line Items]
Operating Income	$ 1,397			$ 3,184			$ 5,533	$ 8,256

Fair Value - Summary of Financial Assets and Liabilities Measured at Fair Value (Detail) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	Nov. 02, 2019	Jan. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest Rate Swap Contract (included in Other Assets)		$ 85
Total Assets		85
Cross-Currency Interest Rate Swap Contract (included in Other Long-Term Liabilities)	$ 329	600
Interest Rate Swap Contract (included in Other Long-Term Liabilities)	88
Earnout Liability (included in Other Long-Term Liabilities)	14	14
Total Liabilities	431	614
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest Rate Swap Contract (included in Other Assets)		85
Total Assets		85
Cross-Currency Interest Rate Swap Contract (included in Other Long-Term Liabilities)	329	600
Interest Rate Swap Contract (included in Other Long-Term Liabilities)	88
Total Liabilities	417	600
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Earnout Liability (included in Other Long-Term Liabilities)	14	14
Total Liabilities	$ 14	$ 14

Fair Value - Additional Information (Detail) $ in Millions	9 Months Ended
Fair Value - Additional Information (Detail) $ in Millions	Nov. 02, 2019 USD ($) yr
Fair Value Inputs Assets Liabilities Quantitative Information [Line Items]
Fair value assumptions \| yr	7
Measurement Input, Discount Rate [Member] \| Minimum [Member]
Fair Value Inputs Assets Liabilities Quantitative Information [Line Items]
Fair value assumptions	0.0268
Measurement Input, Discount Rate [Member] \| Maximum [Member]
Fair Value Inputs Assets Liabilities Quantitative Information [Line Items]
Fair value assumptions	0.049
Contingent Earn Out Liability [Member]
Fair Value Inputs Assets Liabilities Quantitative Information [Line Items]
Estimated earnout targets	$ 0.5
Estimated earnout targets	$ 1.4
Contingent Earn Out Liability [Member] \| Minimum [Member]
Fair Value Inputs Assets Liabilities Quantitative Information [Line Items]
Probability of success	0.00%
Contingent Earn Out Liability [Member] \| Maximum [Member]
Fair Value Inputs Assets Liabilities Quantitative Information [Line Items]
Probability of success	0.90%

Fair Value - Schedule of Company's Long-Term Debt Including the Current Portion Not Reflected in Financial Statements at Fair Value (Detail) - USD ($) $ in Thousands	Nov. 02, 2019	Jan. 31, 2019
Fair Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-Term Debt and Related Current Maturities	$ 14,545	$ 18,857
Fair Value [Member] \| Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-Term Debt and Related Current Maturities	14,545	18,857
Carrying Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-Term Debt and Related Current Maturities	$ 14,244	$ 18,242

Subsequent Event - Additional Information (Detail) - Revolving Credit Facility [Member] - USD ($) $ in Millions	Dec. 09, 2019	Nov. 02, 2019
Third Amendment [Member]
Subsequent Event [Line Items]
Maximum borrowing capacity		$ 10.0
Subsequent Event [Member] \| Fourth Amendment [Member]
Subsequent Event [Line Items]
Maximum borrowing capacity	$ 17.5